DOAC prescription in specific scenarios. DOAC use according to thrombosis location (A) and patient population (B) among prescribers (n = 85). APS, antiphospholipid syndrome; CSVT, cerebral sinus venous thrombosis; DVT, to deep vein thrombosis.